40 min listen
Knowing Is Not Enough, We Must Apply: SGLT2 Inhibitors as Foundational Therapy for HFrEF
FromKeeping Current
Knowing Is Not Enough, We Must Apply: SGLT2 Inhibitors as Foundational Therapy for HFrEF
FromKeeping Current
ratings:
Length:
35 minutes
Released:
Sep 16, 2021
Format:
Podcast episode
Description
Drs Petrie and Zieroth use multiple cases to discuss the role of SGLT2 inhibitors in the management of HFrEF. Credit available for this activity expires: 9/15/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/958550?src=mkm_podcast_addon_958550
Released:
Sep 16, 2021
Format:
Podcast episode
Titles in the series (100)
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice: Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current